## AIZ: Assurant, Inc. - XLF: Financial Services

### Executive Summary

No thesis match: MRS_10 1.4% below STRENGTH zone (3.0-6.0%); PEG 1.46 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($219.82)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 2, Bearish: 0)

**1. Bank of Nova Scotia Acquires 47,054 Shares of Assurant, Inc. $AIZ**
- Source: MarketBeat | 20251211T084931 | Neutral | Relevance: 99%
- Bank of Nova Scotia significantly increased its stake in Assurant, Inc. (NYSE:AIZ) by 878.5% during the second quarter, purchasing an additional 47,054 shares to own a total of 52,410 shares valued at $10.35 million. This investment activity highlights institutional confidence in Assurant, with other firms also adjusting their positions in the financial services provider. Despite recent insider selling by CEO Keith Demmings, analysts maintain a "Moderate Buy" rating for Assurant, with an average price target of $250.00, suggesting continued growth potential for the company, which also recently increased its quarterly dividend.

**2. Amundi Lowers Stake in Assurant, Inc. $AIZ**
- Source: MarketBeat | 20251211T083131 | Somewhat-Bullish | Relevance: 99%
- Amundi significantly reduced its holdings in Assurant, Inc. by 74.9% during the second quarter, now owning 91,976 shares worth approximately $17.6 million. Despite Amundi's reduction, other institutional investors like Charles Schwab and UBS AM increased their stakes, bringing total institutional ownership to 92.65%. Assurant also announced an increased quarterly dividend and received a "Moderate Buy" consensus rating from analysts with an average target price of $250.00.

**3. California Public Employees Retirement System Decreases Stock Holdings in Assurant, Inc. $AIZ**
- Source: MarketBeat | 20251211T094755 | Somewhat-Bullish | Relevance: 99%
- The California Public Employees Retirement System (CalPERS) reduced its stake in Assurant, Inc. (NYSE:AIZ) by 18.5% in the second quarter, now holding 206,053 shares valued at approximately $40.7 million. While institutional ownership remains high at 92.65%, other major funds like Vanguard and Bank of New York Mellon increased their positions. Equity analysts have a "Moderate Buy" consensus rating with an average target price of $250.00, and Assurant recently increased its quarterly dividend to $0.88.

**4. Zacks Research Has Pessimistic View of Assurant Q1 Earnings**
- Source: MarketBeat | 20251211T114928 | Neutral | Relevance: 98%
-  Zacks Research has lowered its Q1 2026 EPS estimate for Assurant (NYSE:AIZ) to $5.15 and maintained a "Hold" rating, projecting a full-year 2026 EPS of $20.75. Despite this, most sell-side analysts have a "Moderate Buy" consensus rating and a $250 price target. Assurant has also increased its quarterly dividend to $0.88, indicating a 1.6% yield, and maintains high institutional ownership of 92.65%, although CEO Keith Demmings recently sold a portion of his shares.

**5. What is Zacks Research's Estimate for Assurant Q2 Earnings?**
- Source: MarketBeat | 20251210T130617 | Somewhat-Bullish | Relevance: 98%
-  Zacks Research has slightly cut its Q2 2027 EPS estimate for Assurant (NYSE:AIZ) to $5.56, while maintaining a "Hold" rating on the stock. The firm also projects Q3 2027 EPS of $5.94 and FY2027 EPS of $22.44, with an overall "Moderate Buy" consensus from analysts and an average target price of $250. Assurant recently raised its quarterly dividend to $0.88, offering a 1.6% yield.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 2, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-20 | Keefe, Bruyette | $254 | $248 | +2% |
| 2025-11-17 | Morgan Stanley | $248 | $232 | +7% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-20 | Keefe, Bruyette | main | Outperform |
| 2025-11-17 | Morgan Stanley | main | Equal-Weight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 1 ($0.00M) |
| Sells | 2 ($0.10M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 55.5% |
| Smart Money | **BEARISH** |
| Net Flow | 0.0% |
| Buying/Selling | 1 / 9 |

**Top Holders:**
- Vanguard Group Inc: 13.2% (-2.0%)
- Bank Of New York Mel: 10.0% (+23.7%)
- Blackrock Inc.: 7.9% (-0.4%)
- T. Rowe Price Invest: 7.7% (-3.5%)
- State Street Corpora: 5.4% (-3.9%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Momentum building: MRS_10 improving +4.1% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 1.46 suggests fair value with growth premium. Balance sheet: strong liquidity (11492000000.0x). Institutional flow bearish (9 selling vs 1 buying).

| Metric | Value |
|--------|-------|
| Market Cap | $11.5B |
| Beta | 0.57 |
| 52W Range | $174.97 - $232.02 |
| Short Interest | 2.3% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.46 |
| Forward P/E | 11.0 |
| Current P/E | 11.7 |
| YoY Growth | 6.8% |
| EPS Direction | RISING |

### Technicals

MRS_10 strengthening from -2.7% to 1.4% (+4.1% in 5 days), confirming momentum buildup. Below STRENGTH zone by 1.6pp (needs >3.0% for momentum thesis). MRS_5 at 2.0% confirms short-term momentum alignment. Full SMA alignment bullish (above 20/50/200 SMAs).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 1.43% (CS: 54) | Neutral |
| RSI_14 | 60.7 | Neutral |
| MACD Histogram | -0.47 | Bearish |
| vs SMA20 | 1.012x | Above |
| vs SMA50 | 1.038x | Above |
| vs SMA200 | 1.108x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $228.02
- **Stop Loss:** $219.82 (3.6% risk)
- **Target:** $236.22 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 168
- **Position Value:** $38,307.36
- **Portfolio %:** 38.31%
- **Risk Dollars:** $1,380.00
- **Risk Per Trade:** 1.38%
- **Modifiers:** L1 115% | L2 120% | Combined 1.38x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX at low 8th percentile signals complacency, but decent breadth and positive yield curve support selective positioning. Focus on quality names with earnings visibility.*

### Earnings

**Next:** 2026-02-10 (Est: $5.24)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $4.28 | $5.73 | +34.0% |
| 2025Q2 | $4.45 | $5.10 | +14.5% |
| 2025Q1 | $2.78 | $3.39 | +22.1% |
| 2024Q4 | $4.13 | $4.79 | +15.9% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_10*